Showing 71 - 80 of 374,755
effects. Standard anti-trust analysis of mergers, in pharmaceuticals as in other industries, focuses on the proposed merger … in the US, because the US healthcare system relies primarily on market forces rather than regulation to assure consumer …
Persistent link: https://www.econbiz.de/10013219540
and South Africa presented a proposal to the World Trade Organization (WTO) in October 2020 seeking a waiver of … vaccination is in place globally, and the majority of the world’s population has developed an immunity.” While the proposal has …
Persistent link: https://www.econbiz.de/10013233828
This Article is based on the 2021 Shidler Lecture, which was delivered at the University of Washington School of Law on November 4, 2021. Through enormous public support and private initiative, biopharmaceutical firms have developed safe and effective COVID-19 vaccines in record time. These...
Persistent link: https://www.econbiz.de/10013297737
Persistent link: https://www.econbiz.de/10000848590
Persistent link: https://www.econbiz.de/10000332058
Persistent link: https://www.econbiz.de/10001702740
Although patents are the prototypical type of protection that most people consider applicable to protecting drugs, patents are just the most-established and well-known method available to protect drugs from competition. However, there are other types of mechanisms in regulatory laws that provide...
Persistent link: https://www.econbiz.de/10014177280
When the Medicare program was created in 1965, outpatient prescription drugs were left out of the benefit package, a decision that maintained consistency with standard private insurance plans of the time. Cost was one factor behind the exclusion, but a more fundamental reason related to the role...
Persistent link: https://www.econbiz.de/10013229909
Persistent link: https://www.econbiz.de/10009739143